Cadrenal Therapeutics (CVKD) PT Lowered to $13 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts CVKD Hot Sheet
Price: $3.05 +6.64%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Cadrenal Therapeutics (NASDAQ: CVKD) to $13.00 (from $32.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- TNL Mediagene faces Nasdaq delisting over bid price and equity rules
- Nomura/Instinet Reiterates Buy Rating on Dr. Reddy\'s Laboratories (DRRD:IN) (RDY)
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
